Finance

Beta
Lists
ACHC:NASDAQ
Acadia Healthcare Company Inc
$24.48
-2.90%
(-0.73) 1D
$24.48
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHC...
Open
$25.35
High
$25.63
Low
$24.33
Mkt. cap
2.25B
Avg. vol.
2.97M
Volume
2.51M
52-wk high
$30.20
52-wk low
$11.43
EPS
-$12.24
Beta
0.69
Shares outstanding
91.97M
No. of employees
22K
Open
$25.35
High
$25.63
Low
$24.33
Mkt. cap
2.25B
Avg. vol.
2.97M
Volume
2.51M
52-wk high
$30.20
52-wk low
$11.43
EPS
-$12.24
Beta
0.69
Shares outstanding
91.97M
No. of employees
22K
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to ACHC in the past 3 months
Buy
Buy
7
Hold
3
Sell
1
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ACHC in the last 3 months.
Highest
Current $24.48
$39.00 (+59.31%)
Average
$29.00 (+18.46%)
Lowest
$13.00 (-46.90%)
News stories
From sources across the web
Profile
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico. The company is headquartered in Franklin, Tennessee. As of 2024, Acadia operated over 50 inpatient psychiatric hospitals in 19 U.S. states, including Arizona, Arkansas, Florida, Georgia, Indiana, Michigan, Missouri, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Utah, and Wisconsin. It is one of the country's largest hospital systems. It also operates, as of 2024, 165 methadone clinics in 33 states, making it the U.S.'s largest methadone-clinic chain. Acadia was founded as a private corporation in 2005 by Reeve B. Waud and went public in 2011. Wikipedia
About Acadia Healthcare Company Inc
CEOChristopher H. Hunter
Employees22K
Founded2005
Headquarters-
SectorHealth care provider
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.37 / $0.26
+39.68%beat
Revenue / Est. (USD)
828.80M / 823.54M
+0.64%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
869.23M
851.57M
821.46M
828.80M
Cost of goods sold
480.95M
492.58M
491.61M
496.53M
Cost of revenue
480.95M
492.58M
491.61M
496.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.57M
63.21M
60.35M
64.93M
Operating expense
245.98M
239.47M
282.21M
248.44M
Total operating expenses
726.93M
732.05M
773.82M
744.97M
Operating income
142.30M
119.52M
47.64M
83.84M
Other non operating income
-425.00K
-476.00K
-135.46M
-216.00K
EBT including unusual items
50.00M
39.98M
-1.17B
10.96M
EBT excluding unusual items
106.74M
82.43M
-125.74M
45.29M
Income tax expense
12.07M
1.67M
7.84M
6.50M
Effective tax rate
24.13%
4.17%
-0.67%
59.28%
Other operating expenses
134.41M
128.79M
176.10M
131.08M
Net income
30.13M
36.25M
-1.18B
4.10M
Net profit margin
3.47%
4.26%
-143.34%
0.50%
Earnings per share
0.83
0.72
0.07
0.37
Interest and investment income
-
-
-
-
Interest expense
-35.14M
-36.62M
-37.92M
-38.33M
Net interest expenses
-35.14M
-36.62M
-37.92M
-38.33M
Depreciation and amortization charges
49.00M
47.47M
45.75M
52.43M
EBITDA
191.30M
166.99M
93.40M
136.26M
Gain or loss from assets sale
-8.72M
-
-
-1.22M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more